Olga Oikonomidou

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Nicholas C. Turner, Belinda Kingston, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 352 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial

Peter Henriksen, Peter S Hall, Iain R. Macpherson et al. · Circulation · 2023 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Miguel Martín, Elgene Lim, Mariana Chávez‐MacGregor et al. · Journal of Clinical Oncology · 2024 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer

Richard J. Bownes, Arran Turnbull, Carlos Martínez-Pérez et al. · Breast Cancer Research · 2019 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +17

A simple and robust real-time qPCR method for the detection of PIK3CA mutations

Virginia Álvarez-García, Clare Bartos, Ieva Keraite et al. · Scientific Reports · 2018 · 39 citations · Full text

Life Sciences, Genetics, Oncology +17